Ru-Xing Wang1, Hon-Chi Lee2, Jia-Ping Li1, David O Hodge2, Yong-Mei Cha2, Paul A Friedman2, Thomas M Munger2, Komandoor Srivathsan3, Behzad B Pavri4, Win-Kuang Shen3. 1. Department of Cardiology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi 214023, PR China. 2. Division of Cardiovascular Diseases, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota. 3. Division of Cardiovascular Diseases, Mayo Clinic, Scottsdale, Arizona. 4. Division of Cardiology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.
Abstract
BACKGROUND: Although sudden death (SD) is a rare complication after atrioventricular junction (AVJ) ablation and permanent pacemaker implantation, the risk factors leading to this SD remain unknown. The purpose of this study was to investigate SD and its risk factors after ablate-and-pace strategy for rate control in atrial fibrillation (AF) patients during long-term follow-up. HYPOTHESIS: METHODS: From January 2005 to December 2009, we enrolled into this study 517 AF patients with AVJ ablation and right ventricular pacemaker implantation. Patients were divided into 2 groups, SD and non-SD. Cox proportional hazards models were used to assess potential risk factors for overall mortality and SD. RESULTS: During a mean follow-up of 25.8 ± 18.6 months (range, 3 days to 63.8 months), 53 patients died (15 with SD). Cox proportional hazards models showed that the presence of congestive heart failure, New York Heart Association functional class, chronic renal failure, and nonsustained ventricular tachycardia were risk factors that predicted overall mortality. For SD, the presence of dilated cardiomyopathy and mitral stenosis were associated risk factors. SD was exclusively seen in patients who had narrow QRS complex or right bundle branch block prior to AVJ ablation and pacemaker implantation; SD was not seen in any patient with preexisting complete left bundle branch block. CONCLUSIONS: Dilated cardiomyopathy, mitral stenosis, and baseline QRS morphology should be examined as potential risk factors for SD after AVJ ablation and pacemaker implantation.
BACKGROUND: Although sudden death (SD) is a rare complication after atrioventricular junction (AVJ) ablation and permanent pacemaker implantation, the risk factors leading to this SD remain unknown. The purpose of this study was to investigate SD and its risk factors after ablate-and-pace strategy for rate control in atrial fibrillation (AF) patients during long-term follow-up. HYPOTHESIS: METHODS: From January 2005 to December 2009, we enrolled into this study 517 AFpatients with AVJ ablation and right ventricular pacemaker implantation. Patients were divided into 2 groups, SD and non-SD. Cox proportional hazards models were used to assess potential risk factors for overall mortality and SD. RESULTS: During a mean follow-up of 25.8 ± 18.6 months (range, 3 days to 63.8 months), 53 patients died (15 with SD). Cox proportional hazards models showed that the presence of congestive heart failure, New York Heart Association functional class, chronic renal failure, and nonsustained ventricular tachycardia were risk factors that predicted overall mortality. For SD, the presence of dilated cardiomyopathy and mitral stenosis were associated risk factors. SD was exclusively seen in patients who had narrow QRS complex or right bundle branch block prior to AVJ ablation and pacemaker implantation; SD was not seen in any patient with preexisting complete left bundle branch block. CONCLUSIONS:Dilated cardiomyopathy, mitral stenosis, and baseline QRS morphology should be examined as potential risk factors for SD after AVJ ablation and pacemaker implantation.
Authors: Shajil Chalil; Zaheer R Yousef; Sarkaw A Muyhaldeen; Russell E A Smith; Paul Jordan; Christopher R Gibbs; Francisco Leyva Journal: J Am Coll Cardiol Date: 2006-06-20 Impact factor: 24.094
Authors: M F van Oosterhout; F W Prinzen; T Arts; J J Schreuder; W Y Vanagt; J P Cleutjens; R S Reneman Journal: Circulation Date: 1998-08-11 Impact factor: 29.690
Authors: Laurens F Tops; Martin J Schalij; Eduard R Holman; Lieselot van Erven; Ernst E van der Wall; Jeroen J Bax Journal: J Am Coll Cardiol Date: 2006-09-27 Impact factor: 24.094
Authors: M Gasparini; M Mantica; M Brignole; F Coltorti; P Galimberti; L Gianfranchi; C Menozzi; G Magenta; P Delise; A Proclemer; S Tognarini; R Ometto; F Acquati; R Mantovan Journal: Pacing Clin Electrophysiol Date: 2000-11 Impact factor: 1.976
Authors: C Ozcan; A Jahangir; P A Friedman; P J Patel; T M Munger; R F Rea; M A Lloyd; D L Packer; D O Hodge; B J Gersh; S C Hammill; W K Shen Journal: N Engl J Med Date: 2001-04-05 Impact factor: 91.245
Authors: Ru-Xing Wang; Hon-Chi Lee; Jia-Ping Li; David O Hodge; Yong-Mei Cha; Paul A Friedman; Thomas M Munger; Komandoor Srivathsan; Behzad B Pavri; Win-Kuang Shen Journal: Clin Cardiol Date: 2016-10-17 Impact factor: 2.882
Authors: Osmar Antonio Centurión; Karina Elizabeth Scavenius; Laura B García; Luis Miño; Judith Torales; Orlando Sequeira Journal: J Atr Fibrillation Date: 2018-06-30